Physician profile
Jenna Alysse Bernstein
NPI 1689093775
$272,571.83
in general payments reported to CMS, 2019-2025
16 companies · $82K in 2025
The $82K reported for 2025 was more than what 91% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11K · 2021: $18K · 2022: $25K · 2023: $74K · 2024: $62K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $192K · Travel and Lodging: $16K · Food and Beverage: $7,004 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $191,858.12 |
| Travel and Lodging | $16,412.15 |
| Food and Beverage | $7,004.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,220.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $151,053.06 | 2020-2025 | Actis, Endurance, Velys |
| Smith+Nephew, INC. | $105,450.31 | 2020-2025 | Journey II, Real Intelligence, Tandem |
| Depuy Synthes Products, INC. | $7,915.40 | 2025 | Velys |
| Depuy Synthes Sales INC. | $3,181.09 | 2022-2025 | Attune, Actis, Orthovisc |
| Brixton Biosciences, INC. | $1,796.90 | 2024 | Neural Ice |
| Stryker Corporation | $873.26 | 2020-2023 | Triathlon, Mako |
| Zimmer Biomet Holdings, INC. | $719.93 | 2023-2024 | Tapestry, Persona |
| Globus Medical, INC. | $646.60 | 2021 | |
| Davol INC. | $324.06 | 2022-2023 | Arista Ah Flexitip |
| Orthalign INC | $184.00 | 2022 | |
| Abbvie INC. | $152.80 | 2023 | Qulipta |
| Total Joint Orthopedics, INC. | $90.46 | 2023 | |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Omnilife Science, INC | $61.77 | 2023 | Omnibotics 3.0 |
| Avanos Medical | $43.33 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $16.41 | 2025 | Simponi Aria, Tremfya, Stelara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.